
### [MONDO:0017720](http://purl.obolibrary.org/obo/MONDO_0017720)
**Label:** GM2 gangliosidosis

**Subclasses:** [MONDO:0017721](http://purl.obolibrary.org/obo/MONDO_0017721) (Sandhoff disease, infantile form), [MONDO:0017723](http://purl.obolibrary.org/obo/MONDO_0017723) (Sandhoff disease, adult form), [MONDO:0017722](http://purl.obolibrary.org/obo/MONDO_0017722) (Sandhoff disease, juvenile form), [MONDO:0010099](http://purl.obolibrary.org/obo/MONDO_0010099) (Tay-Sachs disease AB variant), [MONDO:0010100](http://purl.obolibrary.org/obo/MONDO_0010100) (Tay-Sachs disease), [MONDO:0017728](http://purl.obolibrary.org/obo/MONDO_0017728) (Tay-Sachs disease, B1 variant), [MONDO:0017725](http://purl.obolibrary.org/obo/MONDO_0017725) (Tay-Sachs disease, b variant, juvenile form), [MONDO:0017724](http://purl.obolibrary.org/obo/MONDO_0017724) (Tay-Sachs disease, b variant, infantile form), [MONDO:0010006](http://purl.obolibrary.org/obo/MONDO_0010006) (Sandhoff disease), [MONDO:0017726](http://purl.obolibrary.org/obo/MONDO_0017726) (Tay-Sachs disease, b variant, adult form), 

**Corr. equiv. classes:** [OMIM:272800](http://purl.obolibrary.org/obo/OMIM_272800), [Orphanet:309192](http://www.orpha.net/ORDO/Orphanet_309192), [Orphanet:309162](http://www.orpha.net/ORDO/Orphanet_309162), [Orphanet:309185](http://www.orpha.net/ORDO/Orphanet_309185), [Orphanet:309155](http://www.orpha.net/ORDO/Orphanet_309155), [OMIM:268800](http://purl.obolibrary.org/obo/OMIM_268800), [Orphanet:309178](http://www.orpha.net/ORDO/Orphanet_309178), [Orphanet:309246](http://www.orpha.net/ORDO/Orphanet_309246), [Orphanet:309169](http://www.orpha.net/ORDO/Orphanet_309169), [Orphanet:309239](http://www.orpha.net/ORDO/Orphanet_309239), [Orphanet:845](http://www.orpha.net/ORDO/Orphanet_845), [Orphanet:796](http://www.orpha.net/ORDO/Orphanet_796), [OMIM:272750](http://purl.obolibrary.org/obo/OMIM_272750), 

**Class expressions from DL-Learner:**

- [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and [HP:0100543](http://purl.obolibrary.org/obo/HP_0100543) (Cognitive impairment) 69.23%
- [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0100543](http://purl.obolibrary.org/obo/HP_0100543) (Cognitive impairment) 69.23%
- [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and [HP:0011442](http://purl.obolibrary.org/obo/HP_0011442) (Abnormality of central motor function) and [HP:0100543](http://purl.obolibrary.org/obo/HP_0100543) (Cognitive impairment) 69.23%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and [HP:0100543](http://purl.obolibrary.org/obo/HP_0100543) (Cognitive impairment) 69.23%
- [HP:0001268](http://purl.obolibrary.org/obo/HP_0001268) (Mental deterioration) and [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) 65.38%
- [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and [HP:0100022](http://purl.obolibrary.org/obo/HP_0100022) (Abnormality of movement) and [HP:0100543](http://purl.obolibrary.org/obo/HP_0100543) (Cognitive impairment) 65.38%
- [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) and [HP:0100543](http://purl.obolibrary.org/obo/HP_0100543) (Cognitive impairment) 65.38%
- [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) and [HP:0100543](http://purl.obolibrary.org/obo/HP_0100543) (Cognitive impairment) 65.38%
- [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) and [HP:0100543](http://purl.obolibrary.org/obo/HP_0100543) (Cognitive impairment) 65.38%
- [HP:0002011](http://purl.obolibrary.org/obo/HP_0002011) (Morphological abnormality of the central nervous system) and [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and [HP:0100543](http://purl.obolibrary.org/obo/HP_0100543) (Cognitive impairment) 65.38%
- [HP:0001268](http://purl.obolibrary.org/obo/HP_0001268) (Mental deterioration) and [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 65.38%
- [HP:0001268](http://purl.obolibrary.org/obo/HP_0001268) (Mental deterioration) and [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and [HP:0011442](http://purl.obolibrary.org/obo/HP_0011442) (Abnormality of central motor function) 65.38%
- [HP:0001268](http://purl.obolibrary.org/obo/HP_0001268) (Mental deterioration) and [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) 65.38%
- [HP:0001250](http://purl.obolibrary.org/obo/HP_0001250) (Seizures) and [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and [HP:0100543](http://purl.obolibrary.org/obo/HP_0100543) (Cognitive impairment) 65.38%
- [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) and [HP:0011446](http://purl.obolibrary.org/obo/HP_0011446) (Abnormality of higher mental function) 61.49%


